Aurora Cannabis (ACB) Restructuring Costs (2019 - 2025)
Aurora Cannabis (ACB) posted quarterly Restructuring Costs of -$2.0 million for Q1 2025, down 100.01% year-on-year from $18.2 billion in Q1 2024, and down 356.19% on a QoQ basis from $780991.4 in Q4 2024.
Aurora Cannabis (ACB) Restructuring Costs (2019 - 2025) Analysis & Trends
Aurora Cannabis (ACB) has reported Restructuring Costs for 7 consecutive years, with -$2.0 million the latest figure, recorded in Q1 2025.
- Quarterly Restructuring Costs fell 100.01% year-over-year to -$2.0 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $116.8 million (up 160.41% YoY) and the FY2024 annual result came in at $1.1 million, down 20.5% from the prior year.
- Restructuring Costs retreated to -$2.0 million in Q1 2025 per ACB's latest filing, from $780991.4 in the prior quarter.
- Over the last five years, Restructuring Costs for ACB reached as high as $183.0 million in Q3 2024 and fell as low as -$351.0 million in Q3 2023.
- A 5-year average of -$5.0 million and a median of -$699192.9 in 2022 frame the typical range for Restructuring Costs.
- The largest YoY upside for Restructuring Costs was 20739.66% in 2023 against a maximum downside of 45090.38% in 2023.
- Year by year, Restructuring Costs stood at -$429194.8 in 2021, then plunged by 123.31% to -$958450.5 in 2022, then surged by 172.96% to $699277.8 in 2023, then climbed by 11.69% to $780991.4 in 2024, then slumped by 356.19% to -$2.0 million in 2025.
- According to Business Quant data, Restructuring Costs over the past three periods registered -$2.0 million, $780991.4, and $183.0 million for Q1 2025, Q4 2024, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -2.00 Mn |
| Dec 31, 2024 | 780,991.41 |
| Sep 30, 2024 | 183.00 Mn |
| Jun 30, 2024 | -65.00 Mn |
| Mar 31, 2024 | -1.00 Mn |
| Dec 31, 2023 | 699,277.82 |
| Sep 30, 2023 | -351.00 Mn |
| Jun 30, 2023 | 158.00 Mn |
| Dec 31, 2022 | -958,450.52 |
| Sep 30, 2022 | -776,713.95 |
| Jun 30, 2022 | -765,516.48 |
| Mar 31, 2022 | -221,842.59 |
| Dec 31, 2021 | -429,194.82 |
| Sep 30, 2021 | -1.06 Mn |
| Jun 30, 2021 | 1.64 Mn |
| Mar 31, 2021 | -632,869.40 |
| Dec 31, 2020 | -322,162.96 |
| Sep 30, 2020 | 157,588.97 |
| Jun 30, 2020 | 551.13 Mn |
| Dec 31, 2019 | -577.39 Mn |